These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


497 related items for PubMed ID: 10335000

  • 1. Randomised trial of an inhaled beta2 agonist, inhaled corticosteroid and their combination in the treatment of asthma.
    Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Wong CS, Taylor DR.
    Thorax; 1999 Jun; 54(6):482-7. PubMed ID: 10335000
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma.
    Aldridge RE, Hancox RJ, Robin Taylor D, Cowan JO, Winn MC, Frampton CM, Town GI.
    Am J Respir Crit Care Med; 2000 May; 161(5):1459-64. PubMed ID: 10806139
    [Abstract] [Full Text] [Related]

  • 4. Effects of inhaled beta agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma.
    Hancox RJ, Stevens DA, Adcock IM, Barnes PJ, Taylor DR.
    Thorax; 1999 Jun; 54(6):488-92. PubMed ID: 10335001
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.
    Wechsler ME, Kunselman SJ, Chinchilli VM, Bleecker E, Boushey HA, Calhoun WJ, Ameredes BT, Castro M, Craig TJ, Denlinger L, Fahy JV, Jarjour N, Kazani S, Kim S, Kraft M, Lazarus SC, Lemanske RF, Markezich A, Martin RJ, Permaul P, Peters SP, Ramsdell J, Sorkness CA, Sutherland ER, Szefler SJ, Walter MJ, Wasserman SI, Israel E, National Heart, Lung and Blood Institute's Asthma Clinical Research Network.
    Lancet; 2009 Nov 21; 374(9703):1754-64. PubMed ID: 19932356
    [Abstract] [Full Text] [Related]

  • 9. Early asthma control and maintenance with eformoterol following reduction of inhaled corticosteroid dose.
    Price D, Dutchman D, Mawson A, Bodalia B, Duggan S, Todd P, FLOW (Eformoterol in the management of mild astmha--eformoterol Turboinhaler with budesonide Turbohaler) research group.
    Thorax; 2002 Sep 21; 57(9):791-8. PubMed ID: 12200524
    [Abstract] [Full Text] [Related]

  • 10. Maximal response plateau to methacholine as a reliable index for reducing inhaled budesonide in moderate asthma.
    Prieto L, Gutiérrez V, Morales C.
    Eur Respir J; 1999 Jun 21; 13(6):1236-44. PubMed ID: 10445596
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of high and low dose of the inhaled steroid, budesonide, as an initial treatment in newly detected asthma.
    Tukiainen H, Taivainen A, Majander R, Poussa T, Svahn T, Puolijoki H, Terho EO.
    Respir Med; 2000 Jul 21; 94(7):678-83. PubMed ID: 10926339
    [Abstract] [Full Text] [Related]

  • 14. Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years.
    Tattersfield AE, Town GI, Johnell O, Picado C, Aubier M, Braillon P, Karlström R.
    Thorax; 2001 Apr 21; 56(4):272-8. PubMed ID: 11254817
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial.
    Papi A, Marku B, Scichilone N, Maestrelli P, Paggiaro P, Saetta M, Nava S, Folletti I, Bertorelli G, Bertacco S, Contoli M, Plebani M, Barbaro MPF, Spanevello A, Aliani M, Pannacci M, Morelli P, Beghé B, Fabbri LM, AIFASMA Study Group.
    Lancet Respir Med; 2015 Feb 21; 3(2):109-119. PubMed ID: 25481378
    [Abstract] [Full Text] [Related]

  • 20. Budesonide and terbutaline or terbutaline alone in children with mild asthma: effects on bronchial hyperresponsiveness and diurnal variation in peak flow.
    Waalkens HJ, Gerritsen J, Koëter GH, Krouwels FH, van Aalderen WM, Knol K.
    Thorax; 1991 Jul 21; 46(7):499-503. PubMed ID: 1877037
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.